Adequate Treatment Response in Transplant-Ineligible MM Patients
Raymond Thertulien, MD, PhD, discusses high-risk factors for patients with MM.
The Utilization of Combination Therapy in Patients with Diabetes
Key opinion leaders discuss the role of combination therapies in the management of diabetes.
Managing Blood Pressure in Patients With Diabetes
Managing hypertension is a critical aspect of diabetes disease management.
Insurance Authorization Considerations Associated With Rett Syndrome Treatment
Considerations for insurance preauthorization and reauthorization are explored by a key opinion leader.
Treatment Burden Associated with Rett Syndrome
Patients and families facing a Rett syndrome diagnosis experience an array of burdens.
Key Contributors to Long-term Outcomes for Patients With MDD
Drs Chitre and Weaver share their finals thoughts, highlighting key contributors to long-term outcomes for patients with major depressive disorder.
The Impact of Early Effective Treatment in MDD
Early effective treatment strategies can have a significant impact on long-term effects for patients with MDD.
Treatment Strategies for Hyperglycemia
The panel shares insights into the evolution of treatment strategies for patients with diabetes.
Insurance Considerations in Diabetes Management
A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.
Patient Frailty Impacting Multiple Myeloma (MM) Treatment Strategies
Brea C. Lipe, MD, highlights considerations for frail patients when treating for MM.
SWOG777 Trial and DRd vs VRd
Medical experts explore the SWOG-S0777 trial and present an overview of daratumumab in combination with lenalidomide and dexamethasone (DRd) vs bortezomib, lenalidomide, and low-dose dexamethasone (VRd).
Patient Education and Proper Inhaler Technique
Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities.
Optimal Management of COPD: Escalation and De-escalation of Therapy
Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts.
Rett Syndrome: The Diagnostic Journey (Part 2)
Patient advocate Paige Nues elaborates on the patient journey associated with a Rett syndrome diagnosis.
Rett Syndrome: The Diagnostic Journey (Part 1)
Paige Nues, from the International Rett Syndrome Foundation, provides insights on the diagnostic journey for patients with Rett syndrome.
Aligning MDD Treatment Goals for Payers and Patients
Drs Weaver and Chitre discuss aligning key considerations for payers and goals of therapy for patients in the treatment of MDD.
Supporting Adherence for Patients with MDD
Drs Weaver and Chitre share strategies to support MDD treatment adherence across their patient populations.
Health Inequities Impacting Optimal Treatment for Patients With Psoriasis
Bruce Sherman, MD, FCCP, FACOEM, underlines the impact of health inequities for patients diagnosed with psoriasis.
The Benefits and Limitations of the PASI Score
Maria Lopes, MD, MS, provides an overview of the PASI scoring system.
The Impact of Psoriasis on the Quality of Life
Amy McMichael, MD, discusses the impact of psoriasis on a patient’s quality of life.
Prevalence and Incidence of Psoriasis
Ryan Haumschild, PharmD, MS, MBA, leads a panel discussion highlighting the current prevalence of psoriasis.
Patient Outcomes Impacted by HoFH
Dr Brinton provides insights regarding prognosis for patients with HoFH.
Overview of Homozygous and Heterozygous Familial Hypercholesterolemia (HoFH)
Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH).
Role of Gene Therapy for Rett Syndrome Treatment
David Lieberman, MD, PhD, reviews the potential role and the goals of gene therapy in the treatment of Rett syndrome.
Future Treatment Landscape for Patients With LN
In their closing thoughts, experts emphasize their optimism regarding the direction of LN treatment strategies and resources.
Unmet Needs Surrounding Treatment of Lupus Nephritis
Drs Wells and Larranaga discuss unmet needs in the treatment landscape for patients with lupus nephritis.
Barriers to Care for Patients With LN
Drs Larranaga and Wells describe challenges impacting access to care for patients with LN.
What Would You Change About the EOM?
Constructive advice on improving the Enhancing Oncology Model (EOM) from our expert panel.
Does Pooling Make Sense?
The Enhancing Oncology Model allows pooling of groups of practices for quality measurement, which was not permitted under the OCM.
ASCERTAIN Trial Overview
Guillermo Garcia-Manero, MD, highlights the ASCERTAIN trial in his opening thoughts surrounding MDS in this ASH 2022 post-conference perspective.
